Literature DB >> 22098517

Totally transrectal endoscopic total mesorectal excision (TME).

A M Lacy1, C Adelsdorfer.   

Abstract

Surgical treatment has been in constant evolution in the search for minimizing incisions regardless of the complexity of the operation. Natural Orifice Translumenal Endoscopic Surgery (NOTES) represents this progression of surgery to less invasive procedures. Transanal endoscopic microsurgery (TEM) is an ideal NOTES platform to access the peritoneal cavity endoscopically through the anus and specifically to allow colorectal resections be performed through smaller, or indeed without, abdominal incisions. Transanal rectosigmoidectomy with total mesorectal excision (TME) using TEM is a feasible and oncologically safe option. Such use of currently available combined hybrid laparoendoscopic systems provides a safe platform to define future clinical applications and advantages of NOTES. Furthermore, it stimulates the active development of technologies that will support and enable it.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Mesh:

Year:  2011        PMID: 22098517     DOI: 10.1111/j.1463-1318.2011.02781.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  18 in total

1.  Midterm functional results of taTME with neuromapping for low rectal cancer.

Authors:  W Kneist; N Wachter; M Paschold; D W Kauff; A D Rink; H Lang
Journal:  Tech Coloproctol       Date:  2015-11-11       Impact factor: 3.781

Review 2.  Shifting Paradigms in Minimally Invasive Surgery: Applications of Transanal Natural Orifice Transluminal Endoscopic Surgery in Colorectal Surgery.

Authors:  Grace Clara Lee; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2015-09

3.  Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.

Authors:  Elisabeth C McLemore; Christina R Harnsberger; Ryan C Broderick; Hyuma Leland; Patricia Sylla; Alisa M Coker; Hans F Fuchs; Garth R Jacobsen; Bryan Sandler; Vikram Attaluri; Anna T Tsay; Steven D Wexner; Mark A Talamini; Santiago Horgan
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

4.  AirSeal system insufflator to maintain a stable pneumorectum during TAMIS.

Authors:  G Bislenghi; A M Wolthuis; A de Buck van Overstraeten; A D'Hoore
Journal:  Tech Coloproctol       Date:  2014-11-26       Impact factor: 3.781

5.  Transanal minimally invasive surgery (TAMIS): applications beyond local excision.

Authors:  S Atallah; M Albert; T Debeche-Adams; S Larach
Journal:  Tech Coloproctol       Date:  2012-12-04       Impact factor: 3.781

6.  Euro-NOTES Status Paper: from the concept to clinical practice.

Authors:  K H Fuchs; A Meining; D von Renteln; G Fernandez-Esparrach; W Breithaupt; C Zornig; A Lacy
Journal:  Surg Endosc       Date:  2013-03-30       Impact factor: 4.584

Review 7.  Laparoscopic natural orifice specimen extraction-colectomy: a systematic review.

Authors:  Albert M Wolthuis; Anthony de Buck van Overstraeten; André D'Hoore
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

8.  TAMIS-assisted laparoscopic low anterior resection with total mesorectal excision in a cadaveric series.

Authors:  Elisabeth C McLemore; Alisa M Coker; Bikash Devaraj; Jeffrey Chakedis; Ali Maawy; Tazo Inui; Mark A Talamini; Santiago Horgan; Michael R Peterson; Patricia Sylla; Sonia Ramamoorthy
Journal:  Surg Endosc       Date:  2013-03-14       Impact factor: 4.584

9.  Minilaparotomy to rectal cancer has higher overall survival rate and earlier short-term recovery.

Authors:  Xiao-Dong Wang; Ming-Jun Huang; Chuan-Hua Yang; Ka Li; Li Li
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

10.  Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): a stepwise description of the surgical technique with video demonstration.

Authors:  S Atallah; M Albert; T DeBeche-Adams; G Nassif; H Polavarapu; S Larach
Journal:  Tech Coloproctol       Date:  2013-02-02       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.